GENova Signs Collaboration Agreement With Beckpharma

GENova Biotherapeutics, a US-based biotechnology company, has signed a collaboration deal with Beckpharma, a UK-based pharmaceutical development company involved in cancer treatments.

The two companies are joining forces in their mutual mission to identify, acquire, and out-license promising cancer drugs in an effort that will not only save millions on GENova's R&D budget, but at the same time will significant increase GENova's distribution.

This collaboration will bolster GENova's acquisition activities and funnel more promising drug targets into its drug development pipeline. GENova will also leverage the scientific expertise of Beckpharma's R&D team, as well as its established distribution channels with big pharmaceutical companies.

Furthermore, scientists in both GENova and Beckpharma are examining their current IP portfolios to gain insight into possible synergies between their drug targets, and the possibility of making a stronger, better, combined product by co-ordinating their biotechnologies.